Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
04 October 2019 | Story Valentino Ndaba | Photo Barend Nagel
BCom degree
Prospective students are invited to apply for the new BCom Business and Financial Analytics 2020 intake.

A new qualification has recently been added to the University of the Free State (UFS) curriculum and 30 prospective students still have the opportunity to form part of the BCom with specialisation in Business and Financial Analytics intake for 2020. The deadline for applications has been extended to 31 October 2019. 

Committed to the 4th industrial revolution

This flagship degree has been designed for the 4th Industrial Revolution as it integrates quantitative analysis, computer science, statistics and business. This new qualification will equip graduates to become high-functioning executives in the modern global business world. 

“The Faculty of Economic and Management Sciences identified the need for a BCom programme incorporating some of these skills in a more deliberate way, in order to prepare our graduates for a changing job market,” says Lizette Pretorius, Faculty Manager.

On par with global standards

International institutions such as Harvard Business School, Carnegie Mellon University, Duke University, and Columbia University have led the way by adopting this cohesive approach to business studies. These universities form part of a listing of the 25 top US schools offering Master’s in Business Analytics programmes. 

The UFS is following in these leading institutions as part of its Integrated Transformation Plan (ITP) to produce globally competitive graduates. According to the ITP: “The future state of engaged scholarship will be an important anchor in maintaining the relevance of the academic syllabus, and linking real local needs to the global knowledge project.”

 Click here to complete the application form. 

Please email the form and required documents to Lizette Pretorius at LPretorius@ufs.ac.za.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept